Cannabis/Controlled Substances Research

COGR and AAMC Submit Joint Letter to DEA on Rescheduling Marijuana - read more...

COGR Submits Response to Congressional RFI on Federal Regulation of CBD Products - read more...

COGR Responds to HHS Notice of Proposed Rulemaking “Confidentiality of Substance Abuse Disorder Patient Records” - read more...

COGR and AAMC Submit Joint Comment Letter to NIH on Cannabis RFI (NOT-AT-22-026) - read more...

COGR Submits Letter to DEA on RIN 1117-AB53 Implementation of the Agriculture Improvement Act of 2018 - read more...

Posted 10/21/20

COGR Submits Letter to FDA on Cannabis Research - read more...

Posted 7/16/19

Joint Association Letter on Industrial Hemp - read more...

Posted November 5, 2018

COGR Submits Letter to DEA Regarding Production Quotas for Schedule I & II Controlled Substances - read more...

Posted September 20, 2018

COGR Working Group Develops FAQs on Cannabis Research - read more...

Posted May 1, 2018

COGR Submits Joint Association Letter in Support of HR 5485 - read more...

Posted April 19, 2018